Lv51
1410 积分 2021-06-08 加入
FDA approves first biparatopic antibody therapy
1小时前
已完结
Bispecific and Biparatopic Antibody Drug Conjugates
1小时前
已完结
Pan-cancer single-cell landscape of tumor-infiltrating T cells
3天前
已完结
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
27天前
已完结
Human kallikrein 2: A novel lineage-specific surface target in prostate cancer
1个月前
已完结
Targeting PD-1+ T cells with small-format immunocytokines enhances IL-12 antitumor activity
2个月前
已完结
Intratumoral delivery of 4-1BBL boosts IL-12-triggered anti-glioma immunity
2个月前
已完结
Linking tumour angiogenesis and tumour immunity
2个月前
已完结
Engineering of conserved residues near antibody heavy chain complementary determining region 3 (HCDR3) improves both affinity and stability
2个月前
已完结
Biogenesis and engineering of interleukin 12 family cytokines
2个月前
已完结
皖公网安备34019202002308
